The absorption of 6°CoB12 has been studied in a group of patients suffering from megaloblastic anaemia associated with pregnancy and in a control group.
Malabsorption of vitamin B,2 does not appear to play a significant role in the pathogenesis of this form of megaloblastic anaemia.
The role of deficient intake, impaired absorption, and loss of anti-megaloblastic factors in the pathogenesis of megaloblastic anaemias associated. with pregnancy is obscure. Recent investigations have drawn attention to absorption defects in this group. Chanarin, Anderson, and Mollin (1958) have presented evidence suggesting some impairment in the absorption of folic acid in normal or apparently normal pregnancy, and Baker (1958) finds that the common cause of megaloblastic anaemia in pregnancy in India is a vitamin B., deficiency due primarily to the presence of an intestinal lesion which impairs B12 absorption.
In Bantu adults in South Africa megaloblastic anaemia is encountered most frequently following pregnancy (Cassel and Metz, 1958) . The condition appears to differ from the megaloblastic anaemias of pregnancy in white races, in that it often presents some months after confinement. While 64% of cases occur within three months after delivery, 20% of the patients present with anaemia more than six months after confinement (Metz, 1958 
Materil and, Methods
The subjects investigated were Bantu hospital patients. All had been delivered within the previous year, and were still lactating. Two groups were studied.
Controls.-These were 20 non-anaemic subjects who were convalescing from various diseases, e.g., pneumonia, not usually affecting absorption from the gastrointestinal tract. The relation to pregnancy is shown in Table I . Table I .
The haematological methods employed were standard (Dacie, 1954) . The absorption of radioactive vitamin B12 was studied by a modification of the Schilling test, as described previously (Metz, Cassel, and Lewis, 1958) .
Results
Controls.-The urinary excretion after oral administration of a dose of 0.6 jug. vitamin B12 labelled with 0.15 _uc. 60Co to the control subjects ranged from 4.3 to 30.2% of the administered dose (mean value 11.3%).
Megaloblastic Anaemia.-The urinary excretion after administration of an identical dose of "0CoB12 to the group of patients with megaloblastic anaemia ranged from 3.9 to 38.7% of the administered dose (mean value 14.6%). The results are detailed in Table I .
Of the 30 patients studied, five showed a urinary recovery of less than 5% of the administered dose of vitamin B12, while only one of the 20 control subjects absorbed less than 5% of the dose. In our clinic normal subjects usually absorb more than 5% of the dose, while patients with Addisonian pernicious anaemia absorb less than 4% of the dose, this defective absorption being corrected by the concomitant administration of intrinsic factor. In two patients where the urinary recovery of 60CoB12 was 3.9% and 4.3 % respectively, the concomitant administration of a potent source of intrinsic factor together with the labelled vitamin B12 did not enhance the absorption of the vitamin.
With the Schilling test, failure to collect all the urine passed during the 24-hour collection period may result in spuriously low values for 60CoB,2 excretion. Of the five patients in the present series with a urinary excretion of less than 5% of the administered dose, the volume of urine passed was 1,300, 1,280, 1,000, 710, and 510 ml. respectively. In the first four of these patients, 
